255 related articles for article (PubMed ID: 33606134)
1. Characterizing Biomedical HIV Prevention Awareness and Use Among Black Transgender Women in the United States.
Chandler CJ; Creasy SL; Adams BJ; Eaton LA; Bukowski LA; Egan JE; Friedman MR; Stall RD; Whitfield DL
AIDS Behav; 2021 Sep; 25(9):2929-2940. PubMed ID: 33606134
[TBL] [Abstract][Full Text] [Related]
2. Examining the Awareness, Acceptability, and Adoption of Conventional and non-conventional Forms of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among jail-involved Black Sexual Minority men (BSMM) and Black Transgender Women (BTW) in Two Diverse US Cities.
Jones MD; Jones K; Almirol E; Payne G; Graves B; Schneider JA; Rijos D; Zawitz C; Zimmerman R; Seal DW; Brewer R; DrPH RB
AIDS Behav; 2023 Apr; 27(4):1304-1313. PubMed ID: 36264406
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-Related Stressors, Sex Behaviors, and HIV Status Neutral Care Among Black Men Who Have Sex With Men and Transgender Women in Chicago, USA.
Chen YT; Duncan DT; Del Vecchio N; Timmins L; Pagkas-Bather J; Lacap S; Hotton A; Knox J; Hanson H; Koli K; Durrell M; Dehlin J; Schneider JA
J Acquir Immune Defic Syndr; 2021 Nov; 88(3):261-271. PubMed ID: 34310447
[TBL] [Abstract][Full Text] [Related]
4. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city.
Garnett M; Hirsch-Moverman Y; Franks J; Hayes-Larson E; El-Sadr WM; Mannheimer S
AIDS Care; 2018 Jan; 30(1):9-17. PubMed ID: 28791876
[TBL] [Abstract][Full Text] [Related]
5. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
[TBL] [Abstract][Full Text] [Related]
6. Navigating Barriers and Opportunities: Perceptions of the Non-Occupational Post-Exposure Prophylaxis Care Continuum Among Young Sexual Minority Men, Aged 17-24, in the United States.
O'Neil AM; Zapata JP; Dang M; Lopez-Rios J; Quinn KG; John SA
AIDS Patient Care STDS; 2024 Jun; 38(6):267-274. PubMed ID: 38864761
[TBL] [Abstract][Full Text] [Related]
7. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men.
Eaton LA; Kalichman SC; Price D; Finneran S; Allen A; Maksut J
AIDS Behav; 2017 May; 21(5):1236-1246. PubMed ID: 28108878
[TBL] [Abstract][Full Text] [Related]
8. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
[TBL] [Abstract][Full Text] [Related]
9. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
[TBL] [Abstract][Full Text] [Related]
10. Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study.
Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Walach C; Placido T; Bogoch II
AIDS Patient Care STDS; 2015 Aug; 29(8):431-6. PubMed ID: 26154174
[TBL] [Abstract][Full Text] [Related]
11. The Role of Social Support in HIV Testing and PrEP Awareness among Young Black Men and Transgender Women Who Have Sex with Men or Transgender Women.
Lelutiu-Weinberger C; Wilton L; Koblin BA; Hoover DR; Hirshfield S; Chiasson MA; Nandi V; Usher D; Frye V
J Urban Health; 2020 Oct; 97(5):715-727. PubMed ID: 31898199
[TBL] [Abstract][Full Text] [Related]
12. 'WTF is PrEP?': attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City.
Thomann M; Grosso A; Zapata R; Chiasson MA
Cult Health Sex; 2018 Jul; 20(7):772-786. PubMed ID: 28982311
[TBL] [Abstract][Full Text] [Related]
13. HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.
Oldenburg CE; Le B; Toan T; Thien DD; Huyen HT; Friedman MR; Stall R; Colby D
AIDS Behav; 2016 Dec; 20(Suppl 3):365-370. PubMed ID: 27435073
[TBL] [Abstract][Full Text] [Related]
14. Reactions and Receptivity to Framing HIV Prevention Message Concepts About Pre-Exposure Prophylaxis for Black and Latino Men Who Have Sex with Men in Three Urban US Cities.
Mimiaga MJ; Closson EF; Battle S; Herbst JH; Denson D; Pitts N; Holman J; Landers S; Mansergh G
AIDS Patient Care STDS; 2016 Oct; 30(10):484-489. PubMed ID: 27749110
[TBL] [Abstract][Full Text] [Related]
15. Pre-exposure Prophylaxis Awareness and Use Among Transgender and Nonbinary Individuals in Canada.
Hallarn J; Scheim AI; Bauer GR
J Acquir Immune Defic Syndr; 2024 Aug; 96(4):341-349. PubMed ID: 38916428
[TBL] [Abstract][Full Text] [Related]
16. Characterizing PrEP Awareness and Interest Among Filipina Transgender Women.
Restar AJ; Adia A; Cu-Uvin S; Operario D
AIDS Educ Prev; 2020 Jun; 32(3):212-228. PubMed ID: 32749880
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
[TBL] [Abstract][Full Text] [Related]
18. A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.
Eaton LA; Matthews DD; Driffin DD; Bukowski L; Wilson PA; Stall RD;
Prev Sci; 2017 Jul; 18(5):505-516. PubMed ID: 28101813
[TBL] [Abstract][Full Text] [Related]
19. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
Sevelius JM; Poteat T; Luhur WE; Reisner SL; Meyer IH
J Acquir Immune Defic Syndr; 2020 Aug; 84(5):437-442. PubMed ID: 32692101
[TBL] [Abstract][Full Text] [Related]
20. Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
Morris E; Teplinskaya A; Olansky E; Rinderle JK; Chapin-Bardales J;
MMWR Suppl; 2024 Jan; 73(1):9-20. PubMed ID: 38261546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
